Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes

Bibliographic Details
Main Authors:	Christiansen, Elisabeth, Hansen, Steffen V. F., Urban, Christian, Hudson, Brian D., Wargent, Edward T., Grundmann, Manuel, Jenkins, Laura, Zaibi, Mohamed, Stocker, Claire J., Ullrich, Susanne, Kostenis, Evi, Kassack, Matthias U., Milligan, Graeme, Cawthorne, Michael A., Ulven, Trond
Format:	Online
Language:	English
Published:	American Chemical Society 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654565/

id	pubmed-3654565
recordtype	oai_dc
spelling	pubmed-36545652013-05-15 Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes Christiansen, Elisabeth Hansen, Steffen V. F. Urban, Christian Hudson, Brian D. Wargent, Edward T. Grundmann, Manuel Jenkins, Laura Zaibi, Mohamed Stocker, Claire J. Ullrich, Susanne Kostenis, Evi Kassack, Matthias U. Milligan, Graeme Cawthorne, Michael A. Ulven, Trond American Chemical Society 2013-04-08 /pmc/articles/PMC3654565/ /pubmed/23687558 http://dx.doi.org/10.1021/ml4000673 Text en Copyright © 2013 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Christiansen, Elisabeth Hansen, Steffen V. F. Urban, Christian Hudson, Brian D. Wargent, Edward T. Grundmann, Manuel Jenkins, Laura Zaibi, Mohamed Stocker, Claire J. Ullrich, Susanne Kostenis, Evi Kassack, Matthias U. Milligan, Graeme Cawthorne, Michael A. Ulven, Trond
spellingShingle	Christiansen, Elisabeth Hansen, Steffen V. F. Urban, Christian Hudson, Brian D. Wargent, Edward T. Grundmann, Manuel Jenkins, Laura Zaibi, Mohamed Stocker, Claire J. Ullrich, Susanne Kostenis, Evi Kassack, Matthias U. Milligan, Graeme Cawthorne, Michael A. Ulven, Trond Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
author_facet	Christiansen, Elisabeth Hansen, Steffen V. F. Urban, Christian Hudson, Brian D. Wargent, Edward T. Grundmann, Manuel Jenkins, Laura Zaibi, Mohamed Stocker, Claire J. Ullrich, Susanne Kostenis, Evi Kassack, Matthias U. Milligan, Graeme Cawthorne, Michael A. Ulven, Trond
author_sort	Christiansen, Elisabeth
title	Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
title_short	Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
title_full	Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
title_fullStr	Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
title_full_unstemmed	Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
title_sort	discovery of tug-770: a highly potent free fatty acid receptor 1 (ffa1/gpr40) agonist for treatment of type 2 diabetes
description
publisher	American Chemical Society
publishDate	2013
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654565/
_version_	1611977921773174784

Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes

Similar Items